Results 151 to 160 of about 22,846,314 (192)

Coronary Microcirculation and the No-reflow Phenomenon

open access: yesCurrent Pharmaceutical Design, 2018
The no-reflow phenomenon refers to the post-percutaneous coronary intervention condition in which, despite re-establishing epicardial coronary vessel patency, the flow to the previously ischemic myocardium is markedly reduced.
Dimitris Tousoulis   +2 more
exaly   +6 more sources

No-reflow phenomenon in the heart and brain [PDF]

open access: yesAmerican Journal of Physiology - Heart and Circulatory Physiology, 2018
The no-reflow phenomenon refers to the observation that when an organ is made ischemic by occlusion of a large artery supplying it, restoration of patency in that artery does not restore perfusion to the microvasculature supplying the parenchyma of that
Michael Harrington, Kevin S King
exaly   +4 more sources

Coronary No-Reflow Phenomenon in Clinical Practice

open access: yesCurrent Pharmaceutical Design, 2018
Timely delivered coronary revascularization with no residual anatomical stenosis does not always lead to prompt restoration of anterograde coronary flow and complete myocardial reperfusion.
Edina Cenko   +2 more
exaly   +5 more sources

No-reflow phenomenon in stroke patients: A systematic literature review and meta-analysis of clinical data [PDF]

open access: yesInternational Journal of Stroke
BackgroundThe no-reflow phenomenon refers to the absence of microvascular reperfusion despite macrovascular reperfusion.AimThe aim of this analysis was to summarize the available clinical evidence on no-reflow in patients with acute ischemic stroke ...
Felix C Ng   +2 more
exaly   +3 more sources

The challenges of coronary no‐reflow phenomenon

Catheterization and Cardiovascular Interventions, 2021
Key Points Proof‐of‐concept study demonstrates that intracoronary epinephrine could provide substantial improvement in coronary flow in ST‐elevation myocardial infarction refractory coronary no‐reflow during primary percutaneous coronary intervention.
Brian C. Case, Lowell F. Satler
openaire   +2 more sources

Management of the no-reflow phenomenon

Pharmacology & Therapeutics, 2011
The lack of reperfusion of myocardium after prolonged ischaemia that may occur despite opening of the infarct-related artery is termed "no reflow". No reflow or slow flow occurs in 3-4% of all percutaneous coronary interventions, and is most common after emergency revascularization for acute myocardial infarction.
Michelle J, Butler   +4 more
openaire   +2 more sources

Coronary no-reflow phenomenon

Current Treatment Options in Cardiovascular Medicine, 2005
No-reflow occurs in up to one third of patients with acute myocardial infarction during acute percutaneous intervention, and occasionally during elective interventions, particularly vein graft intervention. Multiple intracoronary medications will restore flow in most cases.
Shereif H, Rezkalla, Robert A, Kloner
openaire   +2 more sources

State of the Art: No-Reflow Phenomenon.

Cardiology clinics, 2020
Primary percutaneous coronary intervention is the preferred reperfusion strategy for the management of acute ST-segment elevation myocardial infarction. No reflow is characterized by the inadequate myocardial perfusion of a given segment without angiographic evidence of persistent mechanical obstruction of epicardial vessels.
Caiazzo, G   +7 more
openaire   +3 more sources

No-Reflow Phenomenon

2016
No-reflow describes a condition in which myocardial blood flow is reduced after a coronary intervention, despite angiographically patent coronary arteries. It is diagnosed by reduced epicardial blood flow in the presence of a seemingly patent coronary artery, however its incidence is thought to be higher than is estimated by clinical judgment or ...
Ismail Dogu Kilic   +3 more
openaire   +1 more source

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.

open access: yesJournal of the American College of Cardiology, 2010
The objective of this study was to investigate the impact of no-reflow phenomenon on 5-year mortality among patients with acute ST-segment elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PCI).
Robert A Byrne, Melchior Seyfarth
exaly   +2 more sources

Home - About - Disclaimer - Privacy